Form 4: Oscar Health CFO Richard Blackley Reports Stock Transactions
SEC Form 4 Filing
Richard Blackley, CFO of Oscar Health, reports the vesting and sale of Class A Common Stock to cover tax obligations.
Summary
- Richard Blackley, the Chief Financial Officer of Oscar Health, Inc. (OSCR), reported transactions involving Class A Common Stock.
- On March 1, 2024, 7,015 and 37,577 restricted stock units vested and were converted into Class A Common Stock.
- Also on March 1, 2024, 7,015 and 37,577 shares were acquired through the vesting of restricted stock units.
- On March 4, 2024, Blackley sold 14,346 shares of Class A Common Stock at a weighted average price of $15.88 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of equity awards, pursuant to a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Blackley directly owns 578,859 shares of Class A Common Stock and 493,028 restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reports routine transactions related to stock vesting and tax obligations. The use of a pre-arranged trading plan suggests no particular change in the executive's outlook on the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to monitor management's perspective on the company's stock.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in the financial industry to gauge executive sentiment and potential future performance.
- Similar filings are routinely made by executives at companies like UnitedHealth Group (UNH) and Cigna (CI), providing investors with insights into their stock transactions.
- The use of Rule 10b5-1 trading plans is a standard method for insiders to sell shares while avoiding accusations of trading on non-public information, aligning with practices seen at other publicly traded healthcare companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased volume of shares traded.
- The sale of shares to cover tax obligations is a normal part of executive compensation and is unlikely to significantly affect employee morale.
Key Dates
| Date | Description |
|---|---|
| December 1, 2021 | Vesting start date for 7,015 restricted stock units in sixteen equal quarterly installments. |
| February 27, 2023 | Date prior to which the Rule 10b5-1 instruction letter was entered into. |
| June 1, 2023 | Vesting start date for 37,577 restricted stock units in sixteen equal quarterly installments. |
| March 1, 2024 | Vesting and conversion of 7,015 and 37,577 restricted stock units into Class A Common Stock. |
| March 4, 2024 | Sale of 14,346 shares of Class A Common Stock at $15.88 average price. |
| March 5, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.